TEVA logo

TEVA Operating Expenses

Latest reported$2.00B
TEVA Quarterly Operating Expenses ($0.00 → $2.00B)
High-resolution chart · PNG

TEVA operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
2,004,000,000
1,318,000,000
2,355,000,000
1,422,000,000
1,647,000,000
1,358,000,000
2,149,000,000
2,199,000,000
2,029,000,000
1,989,000,000
1,660,000,000
1,507,000,000
2,450,000,000
1,595,000,000
2,625,000,000
1,250,000,000
2,743,000,000
2,453,000,000
1,972,000,000
1,171,000,000
1,291,000,000
1,444,000,000
1,642,000,000
6,194,000,000
1,590,000,000
1,872,000,000
1,809,000,000
1,120,000,000
1,238,000,000
1,201,000,000
1,436,000,000
1,363,000,000
1,316,000,000
1,417,000,000
1,717,000,000
1,735,000,000
1,718,000,000
1,664,000,000
2,124,000,000
1,913,000,000
1,638,000,000
1,532,000,000
1,653,000,000
1,457,000,000
1,571,000,000
1,561,000,000
1,705,000,000
1,655,000,000
1,567,000,000
1,639,000,000
1,859,000,000
1,616,000,000
1,640,000,000
1,631,000,000
1,816,000,000
1,530,000,000
1,595,000,000
1,532,000,000
1,737,000,000
1,145,000,000
1,603,000,000
1,292,000,000
1,349,000,000
1,226,000,000
1,050,000,000
1,145,000,000
1,189,000,000
1,078,000,000
1,067,000,000
1,019,000,000
2,297,000,000
842,000,000
867,000,000
693,000,000
686,000,000
599,000,000
606,000,000
591,000,000
679,800,000
538,100,000
496,100,000
418,400,000
315,300,000
306,400,000
273,200,000
272,800,000
280,600,000
271,900,000
256,200,000
256,200,000
206,500,000
180,100,000
78,400,000
169,100,000
156,600,000
149,000,000
135,500,000
130,300,000
128,137,000
106,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.